V
Verisian
Biotech & Life Sciences · London, United Kingdom · Founded 2023
Verisian accelerates drug time to market with the industry's first platform offering real study traceability (CDISC, SDTM, ADaM, TFLs) MoreLess
Verisian is a pioneering startup in the healthcare and pharmaceutical industry, offering a groundbreaking platform designed to accelerate the time it takes to bring new drugs to market. The company serves pharmaceutical companies, biotech firms, and clinical research organizations (CROs) that are involved in the development and approval of new medications. Verisian operates in the clinical trials and drug development market, a critical sector that demands high levels of accuracy, transparency, and speed.
The core of Verisian's business model is its innovative platform, Verisian Tracer, which provides real study traceability and ensures the integrity of clinical trials. This platform allows clients to track every step of their clinical studies in real-time, ensuring complete transparency and faster development cycles. By parsing study code and leveraging advanced technology, Verisian enables clients to understand exactly what happened during a study, thereby enhancing confidence in the trial's results.
Verisian also offers Verisian Builder, a tool that accelerates the clinical trial study build process. This tool provides access to a rich library of pre-approved TFL (Tables, Figures, and Listings) ADaM (Analysis Data Model) derivation modules. These modules automate the derivation process from eCRF (electronic Case Report Forms), SDTM (Study Data Tabulation Model), and ADaM to TFL, making the study build process more efficient. Additionally, Verisian Builder allows for the extraction and virtualization of derivation paths from existing studies, facilitating effortless code reuse and further speeding up the study build process.
Verisian makes money by offering its platform and tools on a subscription basis or through licensing agreements with its clients. This model ensures a steady revenue stream while providing significant value to its clients by reducing the time and cost associated with drug development.
In summary, Verisian is revolutionizing the clinical trials process with its innovative technology, providing unparalleled study traceability and integrity, and significantly accelerating drug time to market.
Keywords: clinical trials, drug development, study traceability, pharmaceutical, biotech, transparency, Verisian Tracer, Verisian Builder, automation, healthcare innovation.
Company overview
Verisian company information
The essential company record, classifications and operating signals in one place.
- Status
- Operational
- Founded
- 2023
- Headquarters
- London, United Kingdom
- Employees
- 24
- Open positions
- None listed
- Dealroom signal
- 89.1
Valuation & funding
Verisian funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| SEED✓Equity / VC | May 2025 | $5.6M | $22M | Undisclosed | ↗ |
| SEED✓Equity / VC | Sep 2023 | $1.3M | $5.3M | Seedcamp | ↗ |
Financials
Workforce over time
Available workforce history. Financial fields without reported data are omitted.
| Year | Employees |
|---|---|
| 2026 | 24 |
| 2025 | 15 |
| 2024 | 8 |
| 2023 | 5 |
Growth signals
Verisian website traffic
Latest recorded traffic for Verisian is 270 monthly website visits, down 67.9% over the last three months. Verisian's team grew 60% over the past year.
Comparisons
Verisian compared with similar companies
Dealroom’s weighted taxonomy model identifies the closest operating peers. Company identity and context stay open; selected comparison metrics preview what is available in the platform.
Talent graph
Verisian's talent
Source: Dealroom Talent Intelligence.
Global footprint
Where Verisian has talent and traffic
team presence
In the news
Latest news about Verisian
Recent press, funding announcements, and product moves mentioning Verisian — open to read from the original sources.
Market sentiment
What the market is saying about Verisian
An AI-synthesized read of the highest-engagement posts about Verisian on X over the past 7 days. We rank by likes & retweets, ignore corporate channels, and surface the themes that broke out from real people.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Verisian’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.










